SECONDARY HYPERTROPHIC OSTEOARTHROPATHY
Tracking # 20-855982
$99999.00
There are no ratings for this course
Learn moreCourse overview
HYPERTROPHIC OSTEOARTHROPATHY (HOA) IS MAINLY CAUSED BY MAINLY FIBROVASCULAR PROLIFERATION. IT IS CHARACTERIZED BY A COMBINATION OF CLINICAL FINDINGS, INCLUDING SEVERE DISABLING ARTHRALGIA AND ARTHRITIS, DIGITAL CLUBBING, AND PERIOSTOSIS OF TUBULAR BONES WITH OR WITHOUT SYNOVIAL EFFUSION. IT CAN OCCUR AS AN AUTOSOMAL DOMINANT CONDITION CALLED PACHYDERMOPERIOSTOSIS, BUT MORE COMMONLY, IT OCCURS AS A SECONDARY MANIFESTATION OF A CHRONIC PULMONARY OR EXTRAPULMONARY DISEASE OR MALIGNANCY. THIS ACTIVITY OUTLINES THE EVALUATION AND TREATMENT OF HYPERTROPHIC OSTEOARTHROPATHY AND REVIEWS THE INTERPROFESSIONAL TEAM'S ROLE IN CARING FOR PATIENTS WITH THIS CONDITION.
Subject areas
This course counts toward the state boards and subject areas below.